<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-WJKVTNBW</identifier><date>2025</date><creator>Ozkan, Erdem</creator><relation>documents/doc/W/URN_NBN_SI_doc-WJKVTNBW_001.pdf</relation><relation>documents/doc/W/URN_NBN_SI_doc-WJKVTNBW_001.txt</relation><format format_type="issue">4</format><format format_type="volume">59</format><format format_type="type">article</format><format format_type="extent">str. 624-634, XVI</format><identifier identifier_type="DOI">10.2478/raon-2025-0065</identifier><identifier identifier_type="ISSN">1318-2099</identifier><identifier identifier_type="COBISSID">273587715</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-WJKVTNBW</identifier><language>eng</language><publisher publisher_location="[Zagreb]">Croatian Medical Association - Croatian Society of Radiology</publisher><publisher publisher_location="Ljubljana">Slovenian Medical Society - Section of Radiology</publisher><source>Radiology and oncology (Ljubljana)</source><rights>BY</rights><subject language_type_id="slv">imunoterapija</subject><subject language_type_id="slv">onkologija</subject><subject language_type_id="slv">sarkopenija</subject><subject language_type_id="slv">skeletna mišična masa</subject><subject language_type_id="slv">zmanjšana telesna zmogljivost</subject><title>Baseline and dynamic changes in skeletal muscle mass as predictive biomarkers in patients with metastatic renal cell carcinoma treated with Nivolumab</title></Record>